Rankings
▼
Calendar
ARCT FY 2025 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena
ARCT
Arcturus Therapeutics Holdings Inc.
$217M
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$82M
-40.7% YoY
Gross Profit
$0
0.0% margin
Operating Income
-$76M
-93.0% margin
Net Income
$10M
12.3% margin
EPS (Diluted)
$-2.40
Cash Flow
Operating Cash Flow
-$74M
Free Cash Flow
-$74M
Stock-Based Comp.
$25M
Balance Sheet
Total Assets
$271M
Total Liabilities
$57M
Stockholders' Equity
$214M
Cash & Equivalents
$231M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$82M
$138M
-40.7%
Gross Profit
$0
$138M
-100.0%
Operating Income
-$76M
-$96M
+20.3%
Net Income
$10M
-$81M
+112.5%
← Q4 2024
All Quarters
Q1 2025 →